Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,230 | -25,469 | -26,754 | -17,647 | -22,799 |
| Depreciation Amortization | 2,311 | 632 | 570 | 369 | 361 |
| Income taxes - deferred | 164 | N/A | -164 | N/A | N/A |
| Accounts receivable | 5,343 | -4,055 | 12,511 | -14,469 | -59 |
| Accounts payable and accrued liabilities | -4,354 | 1,257 | 764 | -332 | 1,360 |
| Other Working Capital | -16,377 | -32,121 | 21,893 | 63,537 | 6,096 |
| Other Operating Activity | 4,247 | 7,289 | -9,886 | 18,296 | 653 |
| Operating Cash Flow | $-45,896 | $-52,467 | $-1,066 | $49,754 | $-14,388 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,726 | -2,462 | -1,698 | -1,950 | -560 |
| Purchase Of Investment | -41,499 | -59,317 | -117,582 | -43,925 | N/A |
| Sale Of Investment | 83,437 | 71,617 | 110,405 | N/A | N/A |
| Investing Cash Flow | $39,212 | $9,838 | $-8,875 | $-45,875 | $-560 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,115 | 32,166 | 48,511 | 4,090 | 15,221 |
| Financing Cash Flow | $10,115 | $32,166 | $48,511 | $4,090 | $15,221 |
| Exchange Rate Effect | 4,745 | -2,144 | -1,581 | 553 | -267 |
| Beginning Cash Position | 62,260 | 74,867 | 37,878 | 29,356 | 29,350 |
| End Cash Position | 70,436 | 62,260 | 74,867 | 37,878 | 29,356 |
| Net Cash Flow | $8,176 | $-12,607 | $36,989 | $8,522 | $6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,896 | -52,467 | -1,066 | 49,754 | -14,388 |
| Capital Expenditure | -2,726 | -2,462 | -1,698 | -1,950 | -560 |
| Free Cash Flow | -48,622 | -54,929 | -2,764 | 47,804 | -14,948 |